Where the global biotech industry comes to partner
The eleventh annual BIO-Europe Spring® conference is the premier springtime partnering conference for the biotechnology industry. For its 2017 edition, BIO-Europe Spring comes to Barcelona, Spain on March 20–22, 2017.
The conference annually attracts the international “who’s who” from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Attend BIO-Europe Spring and experience how you can have more partnering meetings in the three days of the conference than in the rest of the year.
Based on attendance at previous events, BIO-Europe Spring 2017 will bring together close to 2,400 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in over 12,000 partnering meetings.
Venue: CCIB Convention Centre
Event Date: March 20–22, 2017
Contact:Catharine Moreno Finan EBD Group
In Europe: +49 89 23 88 756 25
In the USA: +1 760 930 0500
cmoreno@ebdgroup.com.com
URL: https://ebdgroup.knect365.com/bioeurope-spring/?utm_source=MSPO&utm_medium=web&utm_term=Advanstar&utm_campaign=BES17
Reg. URL: https://ebdgroup.knect365.com/bioeurope-spring/registration-information?utm_source=MSPO&utm_medium=web&utm_term=Advanstar_reg&utm_campaign=BES17
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.